Centaur Pharmaceuticals Pvt. Ltd is a vertically integrated pharmaceutical company based in Mumbai, India. With over four decades of experience, Centaur has established itself as a leading player in the pharmaceutical industry.

Centaur offers a comprehensive range of products and services across the pharmaceutical value chain, including API, formulations, Contract Research and Manufacturing Services, Clinical Research, R&D, regulatory, and marketing. Their products cater to various therapeutic areas such as ENT, Chest, Pediatrics, Ophthalmology, Neurology, Nephrology, Diabetology, and Cardiology. With a strong focus on quality, Centaur exports its products to 96 countries across five continents, gaining recognition from esteemed doctors, patients, and clients worldwide.

In fact, 42% of their sales come from international markets, highlighting their global acceptance. One of Centaur's remarkable achievements is the co-development of a Globally Patented New Chemical Entity (NCE) called DPOCL, specifically designed for Diabetic Foot Ulcer treatment, addressing an unmet medical need. Additionally, their clinical research division, Lifesan, has collaborated with a German biotechnology company to successfully conduct Phase II and III studies in India.

Committed to growth and innovation, Centaur is focused on leveraging integration synergies, expanding its international footprint, forging strategic alliances, and in-licensing molecules. This strategic global approach enables Centaur to expand its reach, enhance business volumes, mitigate risks, and establish a niche in the global pharmaceutical market. Centaur Pharmaceuticals Pvt.

Ltd's dedicated workforce, comprising 2776 Centaurians, is its most valuable asset. Their collective efforts across facilities, head office, and sales teams drive the company's success. Overall, Centaur Pharmaceuticals Pvt.

Ltd is a trusted name in the pharmaceutical industry, known for its quality products, global outreach, and commitment to improving healthcare outcomes